Skip to main content
Premium Trial:

Request an Annual Quote

Bayer HealthCare Renews, Extends Ariadne Software License Through 2010

NEW YORK (GenomeWeb News) — Ariadne yesterday said that Bayer HealthCare has renewed and expanded a licensing agreement that allows it to use the company’s Pathway Studio through 2010 for toxicology studies and microarray data analysis.
 
The Ariadne data-mining software is used to analyze pathways, signaling networks, and to interpret microarray data, the company said.
 
Ariadne also said it is developing a MedScan toxicology module that holds knowledge of small molecules and their interactions with cells and proteins, which Bayer HealthCare will use in its research.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.